BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 23582572)

  • 1. The skin and hypercoagulable states.
    Thornsberry LA; LoSicco KI; English JC
    J Am Acad Dermatol; 2013 Sep; 69(3):450-62. PubMed ID: 23582572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid syndrome and cutaneous vasoocclusive disorders.
    Grattan CE; Burton JL
    Semin Dermatol; 1991 Sep; 10(3):152-9. PubMed ID: 1931563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulants in dermatology.
    Adya KA; Inamadar AC; Palit A
    Indian J Dermatol Venereol Leprol; 2016; 82(6):626-640. PubMed ID: 27320765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy.
    Asherson RA; Francès C; Iaccarino L; Khamashta MA; Malacarne F; Piette JC; Tincani A; Doria A
    Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S46-51. PubMed ID: 16466624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid syndrome and the skin.
    Gibson GE; Su WP; Pittelkow MR
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):970-82. PubMed ID: 9204065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombophilia and thrombosis in thrombotic thrombocytopenic purpura.
    Potti A; Ramiah V; Ortel TL
    Semin Thromb Hemost; 2005 Dec; 31(6):652-8. PubMed ID: 16388416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercoagulable states.
    Anderson JA; Weitz JI
    Clin Chest Med; 2010 Dec; 31(4):659-73. PubMed ID: 21047574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercoagulable states.
    Anderson JA; Weitz JI
    Crit Care Clin; 2011 Oct; 27(4):933-52, vii. PubMed ID: 22082521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dermatologic manifestations of the antiphospholipid syndrome].
    Francès C; Barete S; Soria A
    Rev Med Interne; 2012 Apr; 33(4):200-5. PubMed ID: 22078802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of acquired thrombophilic disorders in 2011: focus on heparin-induced thrombocytopenia, antiphospholipid syndrome, myeloproliferative neoplasms and paroxysmal nocturnal hemoglobinuria.
    Emadi A; Streiff M
    Arch Iran Med; 2011 Nov; 14(6):401-11. PubMed ID: 22039845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus.
    Higginbotham EA; Zimmerman SA; Howard TA; Schanberg L; Kredich D; Ware RE
    J Rheumatol; 2001 Feb; 28(2):370-2. PubMed ID: 11246680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of fondaparinux in a child with heparin-induced thrombocytopenia.
    Tokgoz H; Caliskan U; Demir M
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):769-71. PubMed ID: 22964766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations of antiphospholipid antibody syndrome.
    Weinstein S; Piette W
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology and assessment of hypercoagulability with lessons from heparin-induced thrombocytopenia.
    Sniecinski RM; Hursting MJ; Paidas MJ; Levy JH
    Anesth Analg; 2011 Jan; 112(1):46-58. PubMed ID: 21081779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some considerations about the hypercoagulable states and their treatments.
    Cacciapuoti F
    Blood Coagul Fibrinolysis; 2011 Apr; 22(3):155-9. PubMed ID: 21346557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.